Supplementary Figure 1 from Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer

crossref(2023)

Cited 0|Views19
No score
Abstract

PDF file - 565K, Nutlin-3 response in osteosarcoma cell lines. Treated osteosarcoma cells were analyzed by Western blotting and FACS analysis

More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined